Hong Kong – On April 25, 2025, The University of Hong Kong (HKU) and Shanghai State-owned Capital Investment Co., Ltd. (Shanghai SSCI, 上海国投) held a significant Framework Agreement Signing Ceremony, marking a pivotal step in fostering innovation and collaboration between Hong Kong and Shanghai.
Leadership Speeches: Charting the Course for Innovation
Professor Max Shen, Vice President (Research) of The University of Hong Kong, emphasized in his speech that HKU has long been committed to translating cutting-edge research into practical applications. Leveraging its deep expertise in engineering, medicine, and interdisciplinary studies, HKU aims to build a global hub for innovation. He expressed enthusiasm about integrating HKU’s academic strengths with Shanghai State-owned Capital Investment Co., Ltd. (上海国投)’s industrial resources to create a “virtuous cycle linking research, industry, and the market”, injecting new momentum into regional innovation.
Dr. Dai Minmin, Deputy Secretary of the Party Committee and President of Shanghai State-owned Capital Investment Co., Ltd. (上海国投), highlighted the corporation’s role as a state-owned capital investment and operational platform, is strategically positioned to focus on “Fund Management + Innovation Incubation”. Shanghai SSCI will continue to deepen and expand its comprehensive collaboration with HKU in industry-academia-research integration and the development of the HKU Shanghai Centre. Leveraging complementary advantages between Shanghai and Hong Kong, Shanghai SSCI aims to jointly advance bilateral cooperation in science and technology innovation, fostering synergies for regional development.
Collaborative Initiatives: Focusing on Three Core Areas The partnership centers on “resource sharing and mutual reinforcement”, with key efforts in:
Joint Talent Cultivation HKU and Shanghai SSCI will open internship platforms for students and faculty to engage in corporate projects. Through enterprise visits, joint training programs, and cross-industry exchanges, the initiative will build a cross-border talent network, ensuring robust support for innovation in both regions.
Ecosystem for Technology Commercialization Combining HKU’s talent and R&D capabilities with Shanghai SSCI’s platform resources, the two parties will jointly host innovation and entrepreneurship forums, technology roadshows, and training sessions. These initiatives aim to align academic research with industrial needs, accelerating the commercialization of cutting-edge technologies.
Synergistic Fund Investment The collaboration will establish a mechanism for discovering, connecting, and converting research outcomes across strategic sectors—including integrated circuits, biomedicine, and new energy. By providing early-stage industrial investment and fund services, the partnership will support the growth of tech startups and foster industrial clusters in the Yangtze River Delta and Greater Bay Area.
For more information, please contact: HKU Techno-Entrepreneurship Core Email: hkutec@hku.hk
Geneva, Switzerland – The University of Hong Kong (HKU) announces its successful participation in the 50th International Exhibition of Inventions of Geneva, held from 9 to 13 April, 2025. HKU secured a total of 32 awards, which included one esteemed special grand prize, seven Gold with Jury Congratulations, eight Golds, nine Silvers and seven Bronze medals.
The project Live-attenuated Influenza Vaccine with Alpha-1,3-Galactosyltransferase Expression to Enhance Immune Response won Special Grand Prize – Saudi Innovation Excellence Prize & Gold Medal with Jury Congratulations. It focuses on creating a live-attenuated influenza vaccine that expresses α-Gal epitopes on the surfaces of infected cells. By introducing a gene for alpha-1,3-galactosyltransferase into the neuraminidase gene segment of the influenza virus, the vaccine promotes the opsonization of these infected cells by anti-α-Gal antibodies, thereby enhancing the immune response triggered by the vaccine. This innovative approach aims to improve the efficacy of influenza vaccination. The project is led by Prof Leo L.M. POON and Dr Alex W.H. CHIN from the School of Public Health, LKS Faculty of Medicine.
The other six projects also won Gold Medal with Jury Congratulations, including:
1. A Multimodal Medical Screening and Disease Monitoring Platform to Serve Healthcare Professionals, Patients, and Families in Primary Health Settings with Clinical Standard Readout, Environmental Versatility, and Accessibility
The project aims to provide healthcare professionals, patients, and families with a portable Electrical Impedance Tomography (EIT) system for the early detection and monitoring of vital organs such as the lung, liver, kidney, heart, and brain. Designed for use in primary healthcare settings like clinics, community centers, and homes, this non-invasive technology utilizes advanced microelectronics to measure impedance distribution in organs and generates clinically standard readouts through AI-enabled processing. The EIT system is validated by clinical professionals, offering a unique solution for disease detection and monitoring in community, clinic, and home environments.
It is led by Prof Desmond YAP from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, Dr Russell W. CHAN and Dr Eddie C. WONG.
2. AI-Powered Blood Pressure Monitoring for Everyone
The project focuses on developing a non-invasive method for measuring blood pressure using AI and the built-in sensors of mobile devices, such as microphones, motion sensors, and cameras. This innovative approach allows for convenient home healthcare and continuous monitoring without the need for additional hardware. Key features include the ability to compute various vital signs, telemedicine integration, emergency care capabilities, personalized drug dosage optimization, cost-effectiveness, high scalability, and privacy protection, ensuring that no identifiable data is exposed.
It is led by Mr Nicholas Tze Yin KWOK and Prof Joshua Wing Kei HO from the School of Biomedical Sciences, LKS Faculty of Medicine.
3. Circulating Thrombospondin-2 (TSP2) – A Novel Fibrosis Biomarker for Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
The project focuses on using circulating thrombospondin-2 levels as a simple and non-invasive blood biomarker to predict the presence and progression of advanced liver fibrosis. This biomarker is significant for identifying critical stages of steatotic liver disease, which can influence disease progression in patients with type 2 diabetes and related metabolic disorders.
It is led by Dr Chi-Ho LEE, Prof Karen Siu-Ling LAM and Prof Aimin XU from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine.
4. Compositions and Methods of Gamma-delta T Cell Extracellular Vesicle-based Tumor Vaccines
The project focuses on utilizing extracellular vesicles derived from γδ-T cells as a versatile platform for cancer vaccine development. This approach enhances immune activation and exerts antitumor effects, offering a scalable and ready-to-use solution for various cancers. The technology highlights include the use of γδ-T-EVs to deliver tumor antigens, stimulate immune responses, and directly eliminate tumor cells, ensuring improved safety, effectiveness, and broad applicability in cancer treatment.
It is led by Prof Wenwei TU, Dr Yinping LIU and Dr Xiwei WANG from the Department of Paediatrics & Adolescent Medicine, School of Clinical Medicine, LKS Faculty of Medicine.
5. Hypoxia-Primed Mesenchymal Stromal Cells and Their Derivatives Enhance Lung Injury Repair
The project focuses on preconditioning mesenchymal stromal cells under hypoxic conditions, which simulates the oxygen deprivation seen in tissue damage. This process stimulates the secretion of therapeutic extracellular vesicles enriched with angiogenic factors that facilitate tissue regeneration following acute lung injury. These enhanced extracellular vesicles play a crucial role in promoting recovery from acute lung injuries associated with respiratory diseases.
It is led by Prof Michael Chi Wai CHAN, Dr Angel Po Yee MA, and Dr Rachel Hiu Ha CHING from the School of Public Health, LKS Faculty of Medicine.
6. Methods to Prepare Vdelta2-T Cells Derived Exosomes for Treatment of Epstein-Barr Virus-Associated Cancers
The project focuses on developing techniques to produce exosomes from Vdelta2-T cells (Vδ2-T-Exos) aimed at treating EBV-associated cancers. These exosomes selectively target and kill tumor cells while enhancing T-cell antitumor immunity, providing a stable, scalable, and safer cancer therapy option. The innovation introduces Vδ2-T-Exos, which not only induce apoptosis in EBV-related tumor cells but also bolster T cell-mediated immunity, offering high bioavailability and low side effects, thus presenting a promising cell-free immunotherapy for effective treatment of EBV-related cancer
It is led by Prof Wenwei TU, Dr Yinping LIU and Dr Xiwei WANG from the Department of Paediatrics & Adolescent Medicine, School of Clinical Medicine, LKS Faculty of Medicine.
HKU exhibited 32 groundbreaking projects addressing critical global challenges across various fields, including biomedicine, engineering, and advanced garment manufacturing technology. The innovations presented by HKU reflect the University’s dedication to translating research into practical applications that benefit society.
Among the standout projects were advancements in health technology and novel therapeutic strategies, which garnered attention for their potential to improve health outcomes and enhance quality of life. These inventions exemplify HKU’s mission to foster innovation that address pressing societal needs.
Professor Max Shen, Vice-President and Pro-Vice-Chancellor (Research), expressed pride in the researchers’ accomplishments: “Our participation in the International Exhibition of Inventions of Geneva highlights HKU’s commitment in innovation. We are thrilled to have received 32 awards this year, underscoring the exceptional work of our researchers and their commitment to creating impactful solutions.”
The International Exhibition of Inventions of Geneva serves as a vital platform for inventors, researchers, and industry leaders from around the globe. HKU’s achievements at this event strengthen its role as a leader in innovation and research, contributing to the ongoing development of sustainable solutions and technological advancements.
Please click here for a complete list of HKU’s inventions participated in the event and further details. Please click here to download high-res photos.
For media enquiries, please contact: Mr Antony KWONG Knowledge Exchange Office Email: antonyak@hku.hk
Hong Kong – On March 16, 2025, the University of Hong Kong (HKU) marked a historic milestone with the HKU Super Angel Symposium and the official launch of the HKU Super Angel Network (HKU SAN) during HKU Alumni Day. Held at the Rayson Huang Theatre, the event welcomed an enthusiastic gathering of alumni, entrepreneurs, and supporters, uniting them in a shared vision to advance HKU’s mission of fostering innovation and entrepreneurship.
The day commenced with inspiring opening remarks from Professor Stephanie Ma, Associate Vice-President (Research and Innovation) of HKU. She galvanized attendees with three key messages: HKU’s steadfast dedication to driving innovation, a bold call for alumni and supporters to rally through HKU SAN to empower the next generation of innovators, and an invitation for all to shape the future of HKU’s entrepreneurial ecosystem.
The centerpiece of the event was the launch of the HKU Super Angel Network, heralded as the first initiative of its kind among Hong Kong universities. Led by Dr. Winnie Tang (鄧淑明博士), MH, JP, Chief Convenor of HKU SAN, the network unites alumni and supporters to bolster the startup ecosystem through donations, investments, and mentorship. In her visionary keynote, Dr. Tang emphasized, “This network is about creating a robust support system where experience and networks are shared, enriching the entrepreneurial journey for all.”
The launch was officiated by a distinguished lineup of guests, including:
Their presence marked the celebrated kickoff of this momentous initiative.
The Symposium featured a dynamic program of keynote speeches and panel discussions spotlighting HKU’s trailblazing entrepreneurs. Highlights included a fireside chat between Mr. Ray Chan, CEO & Co-founder of9GAG, and Dr. Paul Wang, Director of Techno-Entrepreneurship Core, delving into the journey of building a global brand, and a presentation by Mr. William Yeung, CEO & Co-founder of MediConCen, on leveraging AI and blockchain to transform insurance claims.
The event’s exceptional panel discussion brought together luminaries including Dr. Winnie Tang, MH, JP; Mr. Hendrick Sin, MH, Founding and Managing Partner at China Prosperity Capital Fund; Mr. Albert Wong, CEO of Hong Kong Science and Technology Parks Corporation (HKSTP); Professor Teng Grace Zhang, Assistant Professor of HKU’s Department of Orthopaedics and Traumatology; and Ms. Rebecca Leung, Co-founder of The Z Label and Former Regional Executive Director of KKday. Together, they offered sharp insights into the future of entrepreneurship, sparking lively debate and inspiration.
The event concluded with a buzzing networking session, fostering connections and creativity. One attendee reflected, “The boldness of this idea is matched only by its potential to transform Hong Kong’s startups, with HKU lighting the way for future innovation.”
HKU extends heartfelt gratitude to the organizing committee and the inaugural supporters of HKU SAN for their invaluable contributions:
A special thank you to the first batch of supporters and the organizing committee of the HKU Super Angel Network for your invaluable contributions.
Organizing Committees:
Prof. Stephanie Ma, HKU, Associate Vice President (Research and Innovation) of HKU
Dr. Winnie Tang, MH, JP, Chief Convenor of HKU Super Angel Network
Mr. Damien Wu, Smart City Consortium
Mr. Albert Leung, Chief Technology Officer of eBRAM
Mr. Dennis Choi, Managing Director of CR Capital
Mr. Sam Fan, Partner of Big Four Accounting Firm
Mr. Fred LI , Managing Director of Gobi Partners
Ms. Monica Wong , Director of HKU Alumni Affairs
Dr. Paul Wang , HKU, Director of HKU TEC
1st Batch HKU SAN’s Supporters:
Dr. George Liu
Fortera Capital
Dr. Fred Fei
Mr. Ray Fung on behalf of Hang Seng Bank
Mr. Chibo Tang on behalf of Gobi Partners
Dr. Nung Chi Norman Sze
Mr. Johnny Mok, SC，BBS，JP
Mr. Daniel Tam Yun Lam
Dr. Joe Mak
Mr. Richard Mak
Mr. Harris Sun
The HKU Super Angel Symposium and the launch of HKU SAN underscore the university’s unwavering commitment to fostering innovation, entrepreneurship, and societal impact. Thank you to all who joined us in making this milestone unforgettable.
For more information about the HKU Super Angel Network and how to get involved, visit www.tec.hku.hk/hkusan.
The HKU Entrepreneurship Engine Fund (EEF) Partnership Agreement Signing Ceremony marked the start of the first round of partner funds under the EEF. Three notable partners— CASSTAR(中科创星), Inno Angels (英诺天使基金) and Beyond Ventures (海闊天空創投) —have collectively pledged HK$370 million to invest in HKU-affiliated start-ups.
The ceremony was graced by the presence of Prof Xiang Zhang, President and Vice-Chancellor; Mrs Margaret M.Y. Leung Ko, Treasurer and Chairman of the Finance Committee, and Prof Max Shen, Vice-President and Pro-Vice-Chancellor (Research), who witnessed this significant occasion.
Prof. Xiang Zhang – President and Vice-Chancellor, HKU
Mrs Margaret M.Y. Leung Ko – Treasurer, HKU
Prof. Max Zuojun Shen – Vice-President and Pro-Vice-Chancellor (Research), HKU
Signing Representatives: HKU: Prof. Stephanie Ma – Associate Vice President (Research & Innovation) InnoAngel: Ms Mavis Wu – Junior Partner Beyond Ventures: Ms Floria Chan– Vice President Witnesses: HKU: Prof. Xiang Zhang – President and Vice-Chancellor, HKU Mrs Margaret Leung – Treasurer Prof Max Shen – Vice-President and Pro-Vice-Chancellor (Research) Mr Jason Chiu – HKU Council Member and EEF Advisory Board Member InnoAngel: Dr Samson Tam – Managing Partner Beyond Ventures: Ms Susan Hu – Venture Partner
Signing Representatives: HKU: Prof. Stephanie Ma – Associate Vice President (Research & Innovation) CASStar: Ms. Lin Xia – Partner Witnesses: HKU: Prof. Xiang Zhang – President and Vice-Chancellor, HKU Mrs Margaret Leung– Treasurer Prof. Max Shen – Vice-President and Pro-Vice-Chancellor (Research) Mr Jason Chiu – Council Member and EEF Advisory Board Member CASStar: Dr Lei Mi – Founding Partner Bank of China Group Investment Limited: Mr Li Sheng – Chairman Mr Wang Jun – Deputy CEO
The EEF partners are committed to actively supporting the university’s innovation and entrepreneurship initiatives through mentorship and financial backing. These early-stage investors will offer valuable expertise in commercialising academic research outcomes and fostering connections between entrepreneurs and industries, both locally and internationally.
The EEF is set to deliver key benefits to HKU, including:
Support for Start-ups: Providing vital financial backing to nurture seed and early-stage deep-tech start-ups
Access to Expertise: Enhancing mentorship and resource-sharing for emerging entrepreneurs through partnerships with leading investors
Fostering Innovation: Driving transformative solutions by connecting academic excellence with entrepreneurial vision.
Dr Paul Wang, Director of Techno-Entrepreneurship Core (TEC), Executive Director of HKU Techno-Entrepreneurship Academy (TEA) and Associate Director of Knowledge Exchange Office
